Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemo-IO and RT +/- Concurrent Chemo in NPC
NCT06095167Phase 3Not yet recruiting
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jan 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Fujian Medical University Cancer Hospital. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT06095167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06095167.